Complete cure of a patient with HBV-associated hepatocellular carcinoma with lung metastasis using interferon and survival up to 108 months: A case report and literature review

Hepatocellular carcinoma (HCC) has a poor prognosis due to its asymptomatic onset and susceptibility to metastasis. The survival of patients with advanced HCC is 6–12 months. As a first-line medicine for the control of hepatitis B virus, interferon (IFN) is also capable of inhibiting tumor growth an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fang, Lv, Hongmin, Li, Yan, Han, Tao, Liu, Hui, Jia, Kefeng, Liu, Fang, Gao, Yanying, Wang, Fengmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096095/
https://www.ncbi.nlm.nih.gov/pubmed/30127887
http://dx.doi.org/10.3892/ol.2018.9033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096095/
https://www.ncbi.nlm.nih.gov/pubmed/30127887
http://dx.doi.org/10.3892/ol.2018.9033

Ejemplares similares